Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
Abstract Clinical application of lentiviral vector (LV)‐based hematopoietic stem and progenitor cells (HSPC) gene therapy is rapidly becoming a reality. Nevertheless, LV‐mediated signaling and its potential functional consequences on HSPC biology remain poorly understood. We unravel here a remarkabl...
Saved in:
| Main Authors: | Francesco Piras, Michela Riba, Carolina Petrillo, Dejan Lazarevic, Ivan Cuccovillo, Sara Bartolaccini, Elia Stupka, Bernhard Gentner, Davide Cittaro, Luigi Naldini, Anna Kajaste‐Rudnitski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2017-06-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201707922 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
by: Luigi Naldini
Published: (2019-01-01) -
Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy
by: Michela Milani, et al.
Published: (2017-08-01) -
Lentiviral-based approach for the validation of cancer therapeutic targets in vivo
by: Chiara Ambrogio, et al.
Published: (2014-10-01) -
Ex vivo-generated lymphoid progenitors encompass both T cell and innate lymphoid cell fates
by: Pierre Gaudeaux, et al.
Published: (2025-07-01) -
Real-World Evidence Data on Adverse Reactions to Infusion of Thawed Hematopoietic Progenitor Cells: Retrospective Analysis from a Single Center in India
by: Aseem K. Tiwari, et al.
Published: (2025-02-01)